Insider · CIK 0001761768
Maria E Martinez
Files at CATX (Perspective Therapeutics, Inc.). First filing -, latest -.
In brief
Maria E Martinez files SEC Form 4 as director at CATX (Perspective Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Maria E Martinez has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 20, 2026 | GSK GSK plc | 44,397 0.00% of outstanding | $2.3M | Aug 20, 2026 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Mar 4, 2026 |
| Sep 3, 2025 | CATX Perspective Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Sep 5, 2025 |
Questions about Maria E Martinez
Answered from the filings on this page, as of the latest one.
Is Maria E Martinez buying or selling?
Maria E Martinez has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Maria E Martinez's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Maria E Martinez has 0.
Where does Maria E Martinez file Form 4?
Maria E Martinez has filed Form 4 at CATX (Perspective Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.